Date published: 2025-9-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

myo-Inositol hexanicotinate (CAS 6556-11-2)

4.0(1)
Write a reviewAsk a question

Alternate Names:
Inositol niacinate; myo-Inositol hexa-3-pyridinecarboxylate
Application:
myo-Inositol hexanicotinate is a nicotinate conjugate of myo-inositol
CAS Number:
6556-11-2
Purity:
≥97%
Molecular Weight:
810.72
Molecular Formula:
C42H30N6O12
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Myo-Inositol hexanicotinate has been used as a niacin source. Although some studies have shown it to reduce levels of serum fatty acids, other studies have shown that there is no reduction of total cholesterol, LDL-C, HDL-C or triglycerides. Inositol niacinate is an nicotinate conjugate of myo-inositol, an structural basis for a number of secondary messengers.


myo-Inositol hexanicotinate (CAS 6556-11-2) References

  1. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic.  |  Vucenik, I. and Shamsuddin, AM. 2003. J Nutr. 133: 3778S-3784S. PMID: 14608114
  2. Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats.  |  Grases, F., et al. 2004. Life Sci. 75: 11-9. PMID: 15102518
  3. Study of a myo-inositol hexaphosphate-based cream to prevent dystrophic calcinosis cutis.  |  Grases, F., et al. 2005. Br J Dermatol. 152: 1022-5. PMID: 15888163
  4. ATR-FTIR investigation on the complexation of myo-inositol hexaphosphate with aluminum hydroxide.  |  Guan, XH., et al. 2006. J Colloid Interface Sci. 293: 296-302. PMID: 16111695
  5. Influence of concomitant food intake on the excretion of orally administered myo-inositol hexaphosphate in humans.  |  Grases, F., et al. 2006. J Med Food. 9: 72-6. PMID: 16579731
  6. Dissolution profiles of nonprescription extended-release niacin and inositol niacinate products.  |  Poon, IO., et al. 2006. Am J Health Syst Pharm. 63: 2128-34. PMID: 17057051
  7. Myo-inositol hexakisphosphate degradation by Bifidobacterium infantis ATCC 15697.  |  Haros, M., et al. 2007. Int J Food Microbiol. 117: 76-84. PMID: 17462768
  8. Phytate (myo-inositol hexaphosphate) and risk factors for osteoporosis.  |  López-González, AA., et al. 2008. J Med Food. 11: 747-52. PMID: 19053869
  9. Phytic acid and myo-inositol support adipocyte differentiation and improve insulin sensitivity in 3T3-L1 cells.  |  Kim, JN., et al. 2014. Nutr Res. 34: 723-31. PMID: 25174657
  10. Protective Effect of Myo-Inositol Hexaphosphate (Phytate) on Abdominal Aortic Calcification in Patients With Chronic Kidney Disease.  |  Sanchis, P., et al. 2016. J Ren Nutr. 26: 226-36. PMID: 26975775
  11. Evaluation of inositol phosphates in urine after topical administration of myo-inositol hexaphosphate to female Wistar rats.  |  Grases, F., et al. 2018. Life Sci. 192: 33-37. PMID: 29155299
  12. Anticancer Properties of Inositol Hexaphosphate and Inositol: An Overview.  |  Vucenik, I. 2019. J Nutr Sci Vitaminol (Tokyo). 65: S18-S22. PMID: 31619624
  13. Intake of myo-inositol hexaphosphate and urinary excretion of inositol phosphates in Wistar rats: Gavage vs. oral administration with sugar.  |  Grases, F., et al. 2019. PLoS One. 14: e0223959. PMID: 31626632
  14. Inositol Hexaphosphate (IP6) and Colon Cancer: From Concepts and First Experiments to Clinical Application.  |  Vucenik, I., et al. 2020. Molecules. 25: PMID: 33333775
  15. Interaction of myo-inositol hexaphosphate (MIHP) with beta-globulin from Sesamum indicum L. Kinetics and thermodynamics.  |  Rajendran, S. and Prakash, V. 1993. Int J Pept Protein Res. 42: 78-83. PMID: 7690352

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

myo-Inositol hexanicotinate, 1 g

sc-215405A
1 g
$194.00

myo-Inositol hexanicotinate, 2 g

sc-215405B
2 g
$245.00

myo-Inositol hexanicotinate, 5 g

sc-215405C
5 g
$296.00

myo-Inositol hexanicotinate, 10 g

sc-215405D
10 g
$326.00

myo-Inositol hexanicotinate, 25 g

sc-215405
25 g
$387.00